Method of diagnosing by determining formic acid to nicotinic aci

Details Method of diagnosing by determining formic acid to nicotinic aci Method of diagnosing by determining formic acid to nicotinic aci

1997-04-25

1999-03-09

Gitomer, Ralph

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

436 64, 436813, C12Q 100

Patent

active

058798803

ABSTRACT:
A method for determining whether a mammal should be medically investigated for a cancerous or pre-cancerous condition based upon the formic acid to nicotinic acid ratio in the blood of the mammal.

REFERENCES:
patent: 4542750 (1985-09-01), Ettare
patent: 4705756 (1987-11-01), Spillert et al.
patent: 5430049 (1995-07-01), Gaut
patent: 5508201 (1996-04-01), Brandt et al.
Tamulevicius P., N--methylnicotinamide as a Possible Prognostic Indicator of Recovery From Leukaemia in Patients Treated with Total-Body Irradiation and Bone Marrow Transplants, Strahlentherapie 160(4):249-254, Jun. 1984.

Affiliated with

Also associated with

Rating

Method of diagnosing by determining formic acid to nicotinic aci does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of diagnosing by determining formic acid to nicotinic aci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing by determining formic acid to nicotinic aci will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1319589